What a whirlwind of activity for patients with diabetes in 2017. New medications, delivery devices, and BG monitoring options, not to mention the oodles of cell phone apps now available for the techno savvy!
Here’s a look at some of the great options approved/and or available in 2017! Combined medications that simplify management for patients, super rapid insulin that may reduce post prandial hyperglycemia, devices that allow patients to enjoy more lifestyle flexibility, integrated insulin pump technology that minimizes risk of hypoglycemia and has the potential to reduce glucose variability. Wow!
|
Name
|
Product
|
|
Xultophy (Novo)
|
Long acting insulin + GLP 1
|
|
Solique (Sanofi)
|
Long acting insulin + GLP 1
|
|
Steglatro (Merck)
|
SGLT-2
|
|
Qtern (Astra-Zeneca)
|
SGLT-2 + DPP4
|
|
Ozempic (Novo)
|
GLP-1
|
|
Jardiance (boehringer-ingelheim)
|
Now FDA approved for the reduction in heart disease related deaths in persons with type 2 diabetes
|
|
FIASP (Novo)
|
Super rapid acting insulin
|
|
T-Slim x 2 (Tandem)
|
Insulin pump with integrated G5 and upload capability to new software
|
|
Freestyle libre flash (Abbott Diabetes Care)
|
Personal CGM
|
|
Dexcom G5
|
Now approved for Medicare patients on MDI who meet the criteria
|
|
Medtronic 670
|
Hybrid closed loop insulin pump and sensor
|
|
Inpen (Companion Medical)
|
Wirelessly enabled pen associated with smart phone
|
|
One touch via (Johnson and Johnson)
|
Bolus only patch pump
|
|
Humalog (Lilly)
|
Junior kwik pen with 0.5 unit dosing
|
I can hardly wait to see what 2018 will hold! New medications? Fingerless BG assessment? And when will the artificial pancreas emerge? I am confident I can now say it is in the not too distant future. I’m looking forward to all the new options for patients in an effort to manage this tedious, and unrelenting diseases!
I wish you all a very Happy New Year and await the next big breakthrough that enhances the lives of all those we work with!
What happened in the diabetes world – 2017? A Recap!
Carla Cox, PhD, RD, CDE, FAADE